Wall Street

Should Medtronic Make The Cut For Your Recovery Watchlist?

Published by
ValueWalk

Investors Have To Ask If Consistent Performance Is EnoughMedtronic (NYSE:MDT) stock is down 6% since the medical device company reported earnings on May 26, 2022. This left shareholders on the outside looking in as the broader market staged a late-week rally. The company’s results weren’t terrible. However, in a market where even the slightest mistake will be punished, it was enough of a disappointment to have investors look for better options. In this article, we’ll take a look at MDT stock so you can decide if it deserves a place on your recovery watchlist. Q1 2022 hedge fund letters, confer…

Read More

Share this Story
Load More Related Articles
Load More In Wall Street